| 000 | 01178 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250512214853.0 | ||
| 264 | 0 | _c19841009 | |
| 008 | 198410s 0 0 eng d | ||
| 022 | _a0305-7453 | ||
| 024 | 7 |
_a10.1093/jac/13.suppl_c.1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKitzis, M D | |
| 245 | 0 | 0 |
_aRecovery period after exposure of Staphylococcus aureus to sub-inhibitory and bactericidal concentrations of rifampicin: clinical implications. _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _cJun 1984 |
||
| 300 |
_a1-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aColony-Forming Units Assay |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aRifampin _xadministration & dosage |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aGutmann, L | |
| 700 | 1 | _aAcar, J F | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 13 Suppl C _gp. 1-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/13.suppl_c.1 _zAvailable from publisher's website |
| 999 |
_c6469768 _d6469768 |
||